Ledger.Open graph →

SEC Form D · Amendment · filed December 28, 2023

Stingray Therapeutics, Inc

Offering

$6.7M

Sold

$6.6M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Dallas, TX

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Jonathan P. Northrup · Dallas, TXExec · Director Sunil P. Sharma · Dallas, TXExec · Director Uma P. Bhatt · Dallas, TXExec · Director Uma P. Bhatt · Dallas, TXExec · Director Jonathan P. Northrup · Dallas, TXExec · Director Sunil P. Sharma · Dallas, TXExec · Director Daria Kuksenko · Boston, MAExec · Director Richard Yoken · White Plains, NYExec · Director Lawrence Bartimer · White Plains, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗